Chemed (CHE) Operating Margin (2009 - 2026)

Chemed has reported Operating Margin for 18 years, with the latest figure at 13.25% in Q2 2026.

• Operating Margin for Q2 2026 came in at 13.25%, up 225.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 13.46% (down 123.0% YoY), and the FY2025 annual result was 13.37%, down 170.0% from the prior year.
• Operating Margin advanced to 13.25% in Q2 2026, from 12.86% in the prior quarter.
• Over five years, Operating Margin peaked at 19.01% in Q4 2023 and troughed at 11.0% in Q2 2025.
• A 5-year average of 14.66% and a median of 14.83% in 2022 frame the typical range for Operating Margin.
• The largest YoY upside for Operating Margin was 413 bps in 2023 against a maximum downside of 475 bps in 2023.
• A 5-year view of Operating Margin shows it stood at 14.88% in 2022, then grew by 28 bps to 19.01% in 2023, then decreased by 6 bps to 17.79% in 2024, then retreated by 12 bps to 15.74% in 2025, then declined by 16 bps to 13.25% in 2026.
• Per Business Quant data, the three most recent Operating Margin figures were 13.25% in Q2 2026, 12.86% in Q1 2026, and 15.74% in Q4 2025.